Tag Archives: Moderna

Pfizer and Moderna reportedly reject invitations to Trump’s vaccine ‘PR stunt’

The Conversation Brazil’s president rejects COVID-19 vaccine, undermining a century of progress toward universal inoculation The world is eagerly awaiting the release of several COVID-19 vaccines, but Brazilian President Jair Bolsonaro is not. “I’m not going to take it. It’s my right,” he said in a Nov. 26 social media broadcast. Bolsonaro, who came down with COVID-19 in July, has also criticized face masks. He and his more faithful supporters oppose any suggestion of mandatory… Source link

Read More »

Moderna hits $58B as it files for COVID-19 vaccine emergency use

TipRanks Billionaire Israel Englander Pours Money Into 2 “Strong Buy” Stocks Following the wild ride that was 2020, where does the market go from here? Major strides have been made in the COVID-19 vaccine race, yet the near-term picture remains unclear, blurred by the virus’ resurgence and the stimulus stalemate on Capitol Hill.In times like these, the investing greats can serve as a source of inspiration, namely billionaire Israel “Izzy” Englander.Who exactly is Englander? The… Source link

Read More »

Moderna says its vaccine is 94.5% effective in preventing COVID-19

By Julie Steenhuysen and Michael Erman Nov 16 (Reuters) – Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations. Together with Pfizer Inc’s vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency… Source link

Read More »

Stock futures advance after new Moderna data stokes vaccine optimism

Stock futures opened higher Tuesday evening after newly published data from Moderna (MRNA) fueled hopes that a vaccine providing protection against Covid-19 would be developed in the relative near-term. Moderna’s vaccine produced neutralizing antibodies in all 45 patients included in an early-stage human safety trial, according to data published after market close by the peer-reviewed New England Journal of Medicine. The data built on earlier promising, but incomplete, results Moderna had… Source link

Read More »